Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.
about
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationRole of oxidants in microbial pathophysiologyIron metabolism and the innate immune response to infectionStructure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanismPseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and deathInhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compoundsDeficiency of α-1-antitrypsin influences systemic iron homeostasisAcquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasiThe peptidoglycan-associated lipoprotein OprL helps protect a Pseudomonas aeruginosa mutant devoid of the transactivator OxyR from hydrogen peroxide-mediated killing during planktonic and biofilm culture.Neutrophil elastase increases airway epithelial nonheme iron levelsCharacterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosaProtease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation.Clinical significance of microbial infection and adaptation in cystic fibrosis.Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway.Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.Pyoverdin is essential for virulence of Pseudomonas aeruginosaEffects of airway surface liquid pH on host defense in cystic fibrosisIron metabolism in the lower respiratory tract.Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.Biotic Interactions Shape the Ecological Distributions of Staphylococcus SpeciesNovel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.The role of iron in pulmonary pathology.Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosisIron-Depletion prevents biofilm formation in Pseudomonas Aeruginosa through twitching mobility and quorum sensing.The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).Human host defense peptide LL-37 prevents bacterial biofilm formation.Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease.Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation.Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin.Increased expression of senescence markers in cystic fibrosis airwaysDifferent anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.The Role of Iron Metabolism in Lung Inflammation and Injury.Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.
P2860
Q24615052-FA3B59F3-080D-489D-B4FB-8B1DD07E98DCQ24683780-26883865-0B71-4D7C-8675-B2933E97A229Q26860448-C181D732-1E44-4754-B650-4F916C3559E5Q27645143-4F983624-24C9-4405-8192-6FEBD0A9E5A5Q28289283-6ADFCBA6-B862-47BD-9810-F861E1539339Q28379616-62A0005F-B6A4-41F1-8F64-09446DD85851Q28393697-BF06771C-B533-40BD-AB67-F0F5548319A7Q30451190-CE8FB0A0-C12F-4632-9F24-5FDDFD9F4808Q33321823-EB28E239-F556-4869-B41B-1A9FE44D0A12Q33801072-41E0FA39-9347-459E-9FFE-90AA2D9F6100Q34008850-48F11937-4D73-4F83-8171-D7F23FA8C26DQ34223156-8B966636-1678-4582-A20C-4CE6688988E3Q34491552-4F143583-F7D7-42A8-8FB7-21C8DF64DE90Q34606483-8E0E4918-8C1F-453E-8B9B-A789A3D3AD72Q34710667-A23F9B0A-CA9E-44BB-86A0-D429234A45F9Q35468143-0584ECC1-2740-4112-918D-8AAB089A265BQ35498296-EA7B4B90-97EB-4329-9FA7-13F1B5F10DB5Q35532562-5CF9C7D1-49B7-413A-9B64-CE5F7DE889A4Q35862783-C9E5A994-A16D-42C3-A678-C8A2F0D662BCQ36114167-5577EEB6-F2F5-4785-AD11-A4D6C5AC71CFQ36177991-AD44F5A2-2DC6-423C-912A-6547F6BA91D3Q36288672-1B655822-D41E-4579-9E2C-879E165BAAC3Q36336719-46600938-5AB3-427E-9CA6-C978B204D084Q36677933-D3AE640E-A3E4-4C42-9A74-4B594F4D2DF5Q36973716-F7FD31A7-CC2A-4DFE-8176-27A54FAF78AFQ37159428-61129C4B-CFD1-4D56-9A8D-A7A529E635D2Q37351609-681A77B4-F967-4F98-8678-0F3D12675B1EQ37447482-3193733D-0023-44BB-B35F-872DE354A6EDQ38021378-703CCD3E-AC43-43C7-ACB6-87583843CC2FQ38289682-B488EEB3-B756-41AB-8331-5F83BC1189F2Q38324668-D3C720E0-3C2F-4F1D-BA31-BD73DADDF362Q39159902-7FB154DA-94D4-4E99-A653-E8519816E678Q39823961-74544AD2-DC83-4505-8192-95222142E2F4Q39829262-943F268C-BA88-4CC3-832D-945FBD296FA7Q41916770-2E6A1820-8B94-4050-8313-489354C852ADQ42589056-0353E557-6CF3-49BE-93DE-767591D1CDEAQ47159364-01DFD2C8-7B8A-4581-A048-B154D61FD1A9Q54970130-A861E54C-1761-473B-8A1E-E0E56209A539
P2860
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Transferrin and lactoferrin un ...... patients with cystic fibrosis.
@en
type
label
Transferrin and lactoferrin un ...... patients with cystic fibrosis.
@en
prefLabel
Transferrin and lactoferrin un ...... patients with cystic fibrosis.
@en
P2093
P2860
P921
P1476
Transferrin and lactoferrin un ...... patients with cystic fibrosis
@en
P2093
B E Britigan
B N Doebbeling
P2860
P304
P407
P577
1993-12-01T00:00:00Z